NCT04426851View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 1358894 is Taken up in the Body and How Food Influences the Amount of BI 1358894 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

October 12, 2020

Study Completion Date

October 12, 2020

Conditions
Healthy
Interventions
DRUG

BI 1358894

Tablet

DRUG

BI 1358894 (C-14) intravenous solution

BI 1358894 mixed with \[carbon labelled (C-14)\] BI 1358894

DRUG

BI 1358894

Oral suspension

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04426851 - A Study in Healthy Men to Test How BI 1358894 is Taken up in the Body and How Food Influences the Amount of BI 1358894 in the Blood | Biotech Hunter | Biotech Hunter